Serveur d'exploration Tocilizumab - Exploration (Accueil)

Index « Teeft.i » - entrée « Nagoya »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Nagasaki university graduate school < Nagoya < Nagoya university graduate school  Facettes :

List of bibliographic references indexed by Nagoya

Number of relevant bibliographic references: 116.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
002905 (2013) The 24th Annual Meeting of Japanese Society of Neuroimmunology (JSNI)
002B48 (2013) Y. Yabe [Japon] ; T. Kojima ; A. Kaneko ; Y. Kanayama ; Y. Hirano ; T. Shioura ; K. Saito [Japon] ; N. Asai ; T. Kobayakawa ; N. IshiguroSAT0143 Analysis of Patients Who Obtained Remission by Disease Activity Score After Tocilizumab Treatment But Still had Low Disease Activity by Clinical Disease Activity Index, and Examination of Points for Treatment Intensification
002B49 (2013) U. Klein [Suisse] ; E. Liang [Suisse] ; B. Vogel [Suisse] ; F. Kolbinger [Suisse] ; G. Bruin [Suisse] ; P. Lloyd [Suisse]SAT0142 Immunogenicity of the Novel Anti-Il-17A Antibody, Secukinumab, with Intravenous and Subcutaneous Dosing Regimens in Healthy Subjects and Patients
002B86 (2013) H. Ishikawa ; Y. Hirano ; A. Kaneko ; D. Kida ; T. Sato ; T. Kojima ; T. Kanamono [Japon] ; N. IshiguroSAT0093 Pregnancy in patients with rheumatoid arthritis treated witn biological agents: Results of the 8-year of japanese tbc registry
002B87 (2013) H. Tsuboi ; S. Akita ; S. Fujita ; M. Hirao ; Y. Saeki [Japon] ; J. Hashimoto [Japon]SAT0092 Ultrasonography of inflamed joints in patients with rheumatoid arthritis; comparison with histopathological analysis
002C36 (2013) OS42: Interstitial Lung Disease 6
002C37 (2013) OS41: Tuberculosis 5
002C38 (2013) OS40: COPD 4
002C39 (2013) OS39: Clinical Allergy & Immunology
002C40 (2013) OS38: Interstitial Lung Disease 5
002C41 (2013) OS37: Tuberculosis 4
002C42 (2013) OS36: COPD 3
002C43 (2013) OS35: Environmental & Occupational Health and Epidemiology
002C44 (2013) OS34: Others 2
002C45 (2013) OS33: Tuberculosis 3
002C46 (2013) OS32: Respiratory Neurobiology and Sleep
002C47 (2013) OS31: Paediatric Lung Disease
002C48 (2013) OS30: Interstitial Lung Disease 4
002C49 (2013) OS29: Bronchoscopy and Interventional Techniques 2
002C50 (2013) OS28: Lung Cancer 6
002C51 (2013) OS27: Respiratory Infections (non‐tuberculosis) 2

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Teeft.i -k "Nagoya" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Teeft.i  \
                -Sk "Nagoya" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Teeft.i
   |clé=    Nagoya
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021